The current phenotypic methods for detecting carbapenemase-producing Enterobacteriaceae (CPE) allow differentiation between class A and B carbapenemases, but they cannot confirm in a single test class D OXA-48 carbapenemase producers. In this study, we evaluated a new phenotypic test, the OXA-48 disk test, which is based on an imipenem disk and two blank disks adjacent to the imipenem disk, loaded with the tested strain and impregnated with EDTA and EDTA plus phenyl boronic acid (PBA), respectively. The evaluation of the OXA-48 disk test was performed with 81 genotypically confirmed OXA-48-type-producing Enterobacteriaceae isolates (41 extended-spectrum ␤-lactamase [ESBL] producers, 3 AmpC producers, and 37 non-ESBL, nonAmpC producers). To measure the specificity of the test, 173 genotypically confirmed OXA-48-negative Enterobacteriaceae isolates (57 Klebsiella pneumoniae carbapenemase [KPC] producers, 34 VIM producers, 23 KPC/VIM producers, 22 NDM producers, and 37 AmpC or ESBL producers and porin deficient) that were nonsusceptible to at least one carbapenem were chosen for testing. Using the imipenem disk and the distortion of the inhibition halo around both blank disks containing EDTA and EDTA/ PBA, the test differentiated all but 3 of the 81 OXA-48 producers (sensitivity of 96.3%). The test was negative for OXA-48 production in all but 4 of the 173 carbapenem-nonsusceptible isolates producing other carbapenemases, AmpCs, or ESBLs (specificity of 97.7%). This evaluation shows that the OXA-48 disk test is an accurate phenotypic method for the direct differentiation of OXA-48-producing Enterobacteriaceae. Its use along with combined disk tests employing inhibitor-supplemented carbapenem disks might allow the differentiation of the currently known carbapenemase types in Enterobacteriaceae species and provide important infection control information.
D
uring the last decade, carbapenem resistance has emerged among Enterobacteriaceae in health care settings and is increasingly being attributed to the production of ␤-lactamases capable of hydrolyzing carbapenems (1) . Among these enzymes, the class A Klebsiella pneumoniae carbapenemases (KPCs) and class B acquired metallo-␤-lactamases (MBLs) have shown rapid international spread, being harbored predominantly by K. pneumoniae and less frequently by other Enterobacteriaceae species (2, 3) . Additionally, the class D OXA-48-type carbapenemases have become increasingly prevalent among the carbapenem-nonsusceptible Enterobacteriaceae in regions of North Africa, the Middle East, and Turkey (1, 4, 5) and subsequently have disseminated and caused outbreaks in several European countries as well as sporadically in South and North America, Israel, and India (1, (6) (7) (8) (9) . Notably, OXA-48-type carbapenemases are spread in K. pneumoniae but also in Escherichia coli and other Enterobacteriaceae species (10) . In contrast to other carbapenemases, these oxacillinases hydrolyze carbapenems weakly, while sparing expanded-spectrum cephalosporins (9) . However, when OXA-48 carbapenemases are associated with the production of extended-spectrum ␤-lactamases (ESBLs) and impaired permeability, the level of resistance conferred to cephalosporins and carbapenems is substantially higher (7, 9, 11) .
The accurate phenotypic detection and differentiation of the various carbapenemase types, including OXA-48-type enzymes, is crucial for controlling the spread of carbapenem resistance among Enterobacteriaceae (3, 12) . The phenotypic detection of carbapenemase-producing organisms was based originally on reduced susceptibility to carbapenems that has to be confirmed by the modified Hodge test (MHT) (13) . While the MHT was found useful for the phenotypic detection of carbapenemase production, the test cannot discriminate between carbapenemase types and may give false-positive results among noncarbapenemase-producing strains (1, 14, 15) . The Carba NP test is also an accurate and simple biochemical test for the first screening of carbapenemase production in Enterobacteriaceae, although it may not be as sensitive for detecting OXA-48 producers (12, (16) (17) (18) . Another version of the Carba NP test (the Carba NP-II) that aims to categorize the different carbapenemase genes was also introduced (17, 19) .
In addition, many clinical laboratories currently test Enterobacteriaceae clinical isolates for the production of class A or class B carbapenemases using various combined disk tests. More specifically, boronic acid derivatives and EDTA or dipicolinic acid have successfully been utilized as inhibitors in disk potentiation tests to differentiate KPC producers from those producing MBLs (20, 21) . However, specific phenotypic methods to differentiate in a single test OXA-48 producers from those producing other carbapenemase types are not available. Recent studies have suggested production of OXA-48 when Enterobacteriaceae species exhibit highlevel resistance to temocillin (22) (23) (24) . However, false-positive results for OXA-48 production by this approach have been obtained for KPC-or MBL-producing strains as well as for AmpC producers with porin loss, which may also exhibit high-level resistance to temocillin (17, 22) . We have also recently shown that a combined disk test using temocillin without and with avibactam could be an adjunctive test to the classic combined disk tests containing boronic acid and EDTA for the discrimination of OXA-48 producers (25) . Additionally, in geographic regions with a high incidence of OXA-48 producers, temocillin and piperacillin-tazobactam susceptibility testing can be used to rule out the presence of OXA-48-producing strains (26) . In the present study, we evaluated the ability of a novel phenotypic method, the OXA-48 disk test, to differentiate accurately in a single test OXA-48-possessing Enterobacteriaceae isolates from those possessing other carbapenemases or those exhibiting reduced carbapenem susceptibility due to ESBL or AmpC production and porin deficiency.
MATERIALS AND METHODS
Clinical isolates. The evaluation of the test was performed with 81 genotypically confirmed OXA-48-type-possessing Enterobacteriaceae of different species. The collection contained clinical isolates of K. pneumoniae (n ϭ 51), Escherichia coli (n ϭ 17), Citrobacter freundii (n ϭ 5), Enterobacter cloacae (n ϭ 4), Serratia marcescens (n ϭ 2), and Klebsiella oxytoca (n ϭ 2) ( Table 1 ). The isolates were recovered during 2008-2014 from separate patients who were hospitalized in various tertiary care Greek and Belgian hospitals.
To measure the specificity of the method to detect OXA-48-mediated resistance, 173 genotypically confirmed OXA-48-negative Enterobacteriaceae clinical isolates were chosen for testing (Table 1) . Non-OXA-48- Subtotal  127  3  11  21  8  3  173 possessing isolates were randomly selected from isolates that possessed KPCs, MBLs, AmpCs, and/or ESBLs and were nonsusceptible to at least one of the carbapenems (imipenem and meropenem MICs of Ͼ1 g/ml; ertapenem MICs of Ͼ0.5 g/ml) (27) . In particular, the collection of non-OXA-48-possessing isolates contained 37 previously characterized carbapenem-nonsusceptible Enterobacteriaceae strains with plasmidic or derepressed AmpCs or ESBLs that were also porin deficient. These 173 isolates came from collections held at the clinical laboratories providing the OXA-48-positive isolates of the present study. The identification of all isolates was confirmed by using the API20E test (bioMérieux, Marcy l'Etoile, France). In addition, the reference NCTC 13442 K. pneumoniae and NCTC 13476 E. coli strains carrying OXA-48-and IMP-type carbapenemases, respectively, were included in the study. Antimicrobial susceptibility testing. Detailed susceptibility analysis was carried out by the agar dilution method following the CLSI guidelines and interpretative criteria (27, 28) . For tigecycline, the U.S. Food and Drug Administration recommendation was used (susceptible, Յ2 g/ml; resistant, Ն8 g/ml) and for colistin, the CLSI recommendation for Acinetobacter spp. (susceptible, Յ2 g/ml; resistant, Ն4 g/ml) was used.
Phenotypic methods for detecting carbapenemase activity, ESBL production, and the differentiation of KPCs and MBLs. Carbapenemase activity was assessed with the modified Hodge test (MHT) using ertapenem and meropenem disks according to the CLSI guidelines (27) . The phenotypic detection of KPC-and/or MBL-possessing Enterobacteriaceae isolates was carried out by a combined disk test with meropenem as a substrate without and with phenyl boronic acid (PBA), EDTA, or both (20) . The likelihood of extended-spectrum ␤-lactamase (ESBL) coproduction was evaluated using a modified CLSI ESBL combined disk test with the addition of both EDTA and boronic acid to all disks (29) .
Molecular testing for ␤-lactamase genes. ␤-Lactamase genes were amplified using a panel of primers for detection of all types of MBLs (30), KPCs (31), OXA-48 (32), plasmid-mediated AmpCs in single PCRs for each gene (33) , and ESBLs, including SHV, TEM, CTX-M, and GES enzymes (34) . The positive controls used were previously characterized isolates from our collection carrying all types of tested ␤-lactamases.
The PCR products were subjected to direct sequencing. They were purified using ExoSAP-IT reagent (USB Corporation, Cleveland, OH) and used as the templates for sequencing on both strands with an ABI Prism 377 DNA sequencer (Applied Biosystems, Foster City, CA).
OXA-48 disk test. The test is based on the use of EDTA to permeabilize the bacterial cell and release ␤-lactamases into the external environment. EDTA was also used to inhibit the production of MBL carbapenemases (35) , while a solution of PBA was used to inhibit the production of KPCs (36) . The stock solution of EDTA was prepared by dissolving anhydrous EDTA (Sigma-Aldrich, Steinheim, Germany) in distilled water at a concentration of 0.1 M (35) . From this solution, 10 l (containing 292 g of EDTA) was dispensed onto two blank paper disks (Becton Dickinson, Sparks, MD). The stock solution of PBA was prepared as previously recommended (36) by dissolving PBA (benzeneboronic acid; Sigma-Aldrich) in dimethyl sulfoxide and water at a concentration of 60 mg/ml. From this solution, 10 l (containing 600 g of PBA) was dispensed onto the right of the two disks containing EDTA (Fig. 1) . The disks were then dried and used within 60 min. The surface of a Mueller-Hinton agar plate (Oxoid Ltd., Basingstoke, Hampshire, England) was inoculated with a lawn of carbapenem-susceptible E. coli ATCC 25922 at a turbidity of 0.5 McFarland standard. A 10-g imipenem disk (Becton Dickinson) was placed on the inoculated surface of the Mueller-Hinton agar. By touching the tops of well-isolated colonies, 2 to 3 colonies of the tested microorganism were applied to coat the disks containing EDTA and EDTA plus PBA. The inoculated disks were placed with the bacterial inoculum (microorganism) side down on the lawn adjacent to the imipenem disk. The plate was then incubated overnight at 35°C in ambient air. After 18 h of incubation, the plates were examined for either an indentation or a flattening of the zone of inhibition, indicating enzymatic inactivation of imipenem (positive result) for either the disk adjacent to the imipenem, or the absence of a distortion of the inhibition halo, indicating no significant inactivation of imipenem (negative result) (Fig. 1) . Indentation of growth toward both EDTA and EDTA/PBA disks indicated production of OXA-48 carbapenemase. Indentation of growth toward the EDTA disk and an absence of growth toward the EDTA/PBA disks was indicative of KPC or KPC plus MBL production. An absence of growth toward both disks containing EDTA and EDTA/PBA indicated production of MBL carbapenemase or nonsusceptibility to carbapenems due to ESBL/AmpC production plus porin loss.
Sensitivity, specificity, and statistical analysis. The performance of the OXA-48 disk test for the detection of OXA-48-possessing Enterobacteriaceae was evaluated by using PCR as the gold standard. For the OXA-48 disk test, the sensitivity was calculated from the number of OXA-48-possessing organisms that were correctly determined, while the specificity was calculated from the number of non-OXA-48-possessing organisms that were correctly determined. Positive and negative predictive values were also calculated.
RESULTS

Antimicrobial susceptibilities.
In this study, bla OXA-48 -positive isolates had substantially lower carbapenem MICs in comparison to those of bla OXA-48 -negative isolates. Carbapenem MICs varied substantially among the 81 OXA-48-positive isolates and ranged from 0.5 to 64 g/ml, from 0.125 to 64 g/ml, and from 0.5 to 128 g/ml for imipenem, meropenem, and ertapenem, respectively. It is of note that as many as 35 (43.2%) of the OXA-48 producers were nonresistant to either imipenem or meropenem (MICs from 0.125 to 2 g/ml) ( Table 2 ). All OXA-48-positive isolates exhibited resistance to ␤-lactam inhibitor combinations (amoxicillinclavulanate or piperacillin-tazobactam), while various resistance rates were observed for cefoxitin, expanded-spectrum cephalosporins (ceftazidime, cefotaxime, and cefepime), and aztreonam. Additionally, 4 OXA-48 producers showed resistance to tigecycline but none to colistin (Table 2) .
Among the 173 OXA-48-negative isolates, carbapenem MICs ranged from 0.5 to 128 g/ml, from 1 to 64 g/ml, and from 1 to 128 g/ml for imipenem, meropenem, and ertapenem, respectively. A larger proportion of these isolates (145; 83.8%) were resistant to either imipenem or meropenem (MICs of Ͼ2 g/ml) in comparison to the OXA-48 producing isolates (Table 2) . Additionally, all isolates were resistant to ␤-lactam inhibitor combinations as well as to cefoxitin, cefotaxime, and ceftazidime.
Phenotypic and molecular screening. PCR and sequencing results showed that all 81 OXA-48-positive isolates contained the OXA-48 variant except two E. coli isolates that contained the OXA-204 variant and two K. pneumoniae isolates that contained the OXA-162 variant. It is notable that application of the MHT revealed that all 81 OXA-48-type-producing isolates gave positive results, irrespectively of the level of resistance to carbapenems. Additionally, all OXA-48-type-producing isolates showed consistently negative results for KPC, MBL, or KPC plus MBL production with the inhibitor-supplemented meropenem disks (data not shown). Moreover, phenotypic testing for ESBL production was in accordance with molecular testing and revealed that 41 of the 81 OXA-48-bearing isolates were also ESBL producers (39 isolates harbored CTX-M types, one harbored an SHV type, and one harbored SHV and CTX-M types), while the remaining 40 isolates were negative for ESBL production (Table 1) . PCR testing revealed also that 3 of the OXA-48-positive isolates possessed plasmid-mediated AmpC genes (2 isolates harbored DHA-1 and 1 isolate harbored CMY-2) ( Table 1 ).
Molecular testing in combination with phenotypic testing of the 173 non-OXA-48-possessing isolates showed that 57 harbored KPCs, 34 harbored VIM-type MBLs, 23 harbored KPC-and VIMtype MBLs, 22 harbored NDM MBLs, and 37 harbored plasmidic or chromosomal derepressed AmpCs or ESBLs with porin deficiency (Table 1) .
OXA-48 disk test. Detailed results of the OXA-48 disk test are shown in Table 3 . With imipenem nonsusceptibility as a screen, the test differentiated all but 3 of the 81 OXA-48-type producers (indentation of the growth toward both EDTA and EDTA/PBA disks; sensitivity of 96.3%) (Fig. 1) . The three test-negative OXA-48-type-producing isolates were identified as E. coli and exhibited very low imipenem and meropenem MICs (0.125 to 0.5 g/ml). More specifically, one of these false-negative isolates was an OXA-204 producer and the remaining two isolates were OXA-48 producers. The OXA-48 disk test was negative for OXA-48 production in all but 4 of the 173 carbapenem-nonsusceptible isolates possessing other carbapenemases, AmpCs, or ESBLs (specificity of 97.7%). Three of the false-positive isolates were K. pneumoniae KPC-2 producers, and one was a K. pneumoniae KPC-2 and VIM-1 producer (Table 3) . Based on these results, the OXA-48 disk test exhibited a positive predictive value (PPV) of 95.1% and a negative predictive value (NPV) of 98.2% for detecting OXA-48 production. Also, the OXA-48-producing control strain yielded a positive result, while the IMP-producing control strain yielded a negative result.
Among the KPC or KPC/VIM producers (n ϭ 80), an indentation of growth toward the EDTA disk and an absence of growth toward the EDTA/PBA disk was detected in 63 isolates (Fig. 1) , while the remaining 17 isolates showed various results. Four of the latter isolates showed an indentation of growth, suggesting OXA-48 production, while in the remaining 13 isolates an absence of growth toward both disks was noticed (Table 3) . Finally, in all MBL-producing isolates (n ϭ 56) as well as in all ESBL-or AmpCproducing isolates (n ϭ 37), an absence of growth toward both the EDTA and EDTA/PBA disks was noticed in all isolates (Fig. 1) , except 4 Enterobacter spp. ESBL-producing isolates that showed an indentation of growth toward the EDTA disk (Table 3) .
DISCUSSION
Optimal screening agents and methods for OXA-48 carbapenemases have yet to be defined (17) . The currently used screens and strategies have indicated that among the carbapenem-nonsusceptible Enterobacteriaceae species, production of OXA-48 can be suspected when the MHT is positive, the inhibitor-based combined disk tests for KPC and MBL production are negative, and a high level of temocillin resistance is detected (23, 24) . In the present evaluation, a single phenotypic test, the OXA-48 disk test provided a straightforward, convenient, and accurate means of detection of OXA-48 carbapenemase in organisms exhibiting reduced susceptibility to carbapenems. The test accurately distinguished between carbapenem nonsusceptibility caused by OXA-48 production and that caused by other carbapenemases (KPC, NDM, VIM, or VIM/KPC), as well as by the production of ESBL or plasmidic AmpC along with reduced outer membrane permeability. It should be noted that the OXA-48 disk test accurately detected OXA-48 producers even in cases of strains that exhibited low carbapenem MICs (imipenem and/or meropenem MICs of Յ2 g/ ml). The test was only negative in three isolates that exhibited very low carbapenem MICs (imipenem and meropenem MICs of 0.125 to 0.5 g/ml). Moreover, the OXA-48 disk test successfully detected OXA-48 carbapenemase not only among K. pneumoniae and E. coli isolates but also among Enterobacteriaceae species sporadically carrying OXA-48 enzymes such as Enterobacter, Serratia, and Citrobacter spp. It is also noteworthy that the indentations of growth toward the imipenem disk from both sides were comparable and well defined, allowing the easy interpretation of OXA-48-positive samples. In contrast, in the four OXA-48 false-positive isolates, the indentation of growth from the site of the disk containing both EDTA and PBA was substantially lower than the indentation of the growth from the site of the disk containing EDTA. Ertapenem or meropenem was not used as the substrate in the present evaluation because imipenem showed better specificity and sensitivity for OXA-48 detection in the preliminary experimental work (data not shown).
Distinguishing between types of mechanisms is a current diagnostic problem for laboratories confronted with the recognition and detection of OXA-48 producers (38) . It is of note that in the OXA-48 disk test coproduction of ESBLs did not interfere with the detection of OXA-48 carbapenemase. Moreover, although it is not within the scope of the present study, the test was able to distinguish KPC and/or VIM/KPC production effectively with a rather high sensitivity and specificity (Table 3 ). The sensitivity of the current indirect test was comparable with that of another indirect carbapenemase test, recently applied for the differentiation of KPC-producing Enterobacteriaceae in a university hospital in the United States (39) . It should be mentioned that a disk test based on the use of EDTA to permeabilize the bacterial cell and release ␤-lactamase into the external environment was initially employed for the detection of plasmidic AmpC ␤-lactamases (40). Our approach differed from the test that employed one paper disk impregnated with EDTA, previously described for KPC detection (39) , since we used a second disk impregnated with both EDTA and boronic acid in order to inhibit KPC production.
In the clinical laboratory, it is crucial to promptly report any isolate with carbapenemase activity to the hospital infection control team to allow the implementation of appropriate contact isolation precautions (11, 41) . In that respect, the OXA-48 disk test, using an imipenem disk and two blank paper disks implemented with EDTA and EDTA plus PBA, respectively, was found to be a convenient procedure that, in contrast with previously proposed methods (22) (23) (24) , may be used effectively for detecting OXA-48 production in a single test. The OXA-48 disk test could also be integrated in an algorithm where this test would be performed on all MHT-positive strains as an identification test for the specific detection of OXA-48 production. In addition, the OXA-48 disk test could be used along with combined disk tests employing inhibitor-supplemented meropenem disks, such as PBA and EDTA (20) in order to differentiate all of the currently known carbapenemase types among Enterobacteriaceae species. Given the need for a test able to differentiate OXA-48 carbapenemase production, the OXA-48 disk test could fill a current gap in diagnostic microbiol- ogy. Adoption of this test would make it possible to learn more about the clinical implications of OXA-48-type enzymes and to contain the spread of organisms possessing this resistance mechanism, particularly in regions with a high incidence of OXA-48-producing Enterobacteriaceae species. The potential benefits also include better patient management and a reduction in the escalation of antibiotic resistance through better infection control.
